21 CFR § 201.311 Labeling

§ 201.311 [Reserved]

Current through Sep 8, 2026 · Read all of Part 201

⚠ 3 pending changes to Part 201

← § 201.310 Phenindione; labeling of drug preparations intended for use by man.§ 201.312 Magnesium sulfate heptahydrate; label declaration on drug products. →